Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.00 EUR
−1.84 M EUR
298.12 K EUR
227.50 M
About MEDMIRA INC
Sector
Industry
CEO
Hermes Hermes Chan
Website
Headquarters
Halifax
Founded
1993
FIGI
BBG000KLXV14
MedMira, Inc. is a biotechnology company, which engages in the development and commercialization of rapid diagnostics and technology platforms. Its products include HIV, Covid-19, Syphilis, Multiplex, Miriad, RVF Toolkit, and H.Pylori. The company was founded by Hermes Hermes Chan and Carlina Hui in 1993 and is headquartered in Halifax, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 47M is 0.06 EUR — it has increased by 26.32% in the past 24 hours. Watch MEDMIRA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange MEDMIRA INC stocks are traded under the ticker 47M.
47M stock has risen by 29.03% compared to the previous week, the month change is a 31.87% rise, over the last year MEDMIRA INC has showed a −2.44% decrease.
47M stock is 27.66% volatile and has beta coefficient of 2.38. Track MEDMIRA INC stock price on the chart and check out the list of the most volatile stocks — is MEDMIRA INC there?
Today MEDMIRA INC has the market capitalization of 39.13 M, it has increased by 0.53% over the last week.
Yes, you can track MEDMIRA INC financials in yearly and quarterly reports right on TradingView.
MEDMIRA INC is going to release the next earnings report on Nov 27, 2024. Keep track of upcoming events with our Earnings Calendar.
47M net income for the last quarter is −530.94 K EUR, while the quarter before that showed −406.30 K EUR of net income which accounts for −30.68% change. Track more MEDMIRA INC financial stats to get the full picture.
No, 47M doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDMIRA INC EBITDA is −1.33 M EUR, and current EBITDA margin is −373.17%. See more stats in MEDMIRA INC financial statements.
Like other stocks, 47M shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDMIRA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDMIRA INC technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDMIRA INC stock shows the sell signal. See more of MEDMIRA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.